JP2013545087A5 - - Google Patents

Download PDF

Info

Publication number
JP2013545087A5
JP2013545087A5 JP2013534031A JP2013534031A JP2013545087A5 JP 2013545087 A5 JP2013545087 A5 JP 2013545087A5 JP 2013534031 A JP2013534031 A JP 2013534031A JP 2013534031 A JP2013534031 A JP 2013534031A JP 2013545087 A5 JP2013545087 A5 JP 2013545087A5
Authority
JP
Japan
Prior art keywords
patient
level
sci
predefined
biomarkers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013534031A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013545087A (ja
JP6071886B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/056338 external-priority patent/WO2012051519A2/en
Publication of JP2013545087A publication Critical patent/JP2013545087A/ja
Publication of JP2013545087A5 publication Critical patent/JP2013545087A5/ja
Application granted granted Critical
Publication of JP6071886B2 publication Critical patent/JP6071886B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013534031A 2010-10-14 2011-10-14 脳損傷のバイオマーカー Active JP6071886B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US39300910P 2010-10-14 2010-10-14
US61/393,009 2010-10-14
US201161436955P 2011-01-27 2011-01-27
US201161436956P 2011-01-27 2011-01-27
US61/436,956 2011-01-27
US61/436,955 2011-01-27
PCT/US2011/056338 WO2012051519A2 (en) 2010-10-14 2011-10-14 Biomarkers of brain injury

Publications (3)

Publication Number Publication Date
JP2013545087A JP2013545087A (ja) 2013-12-19
JP2013545087A5 true JP2013545087A5 (cg-RX-API-DMAC7.html) 2014-12-04
JP6071886B2 JP6071886B2 (ja) 2017-02-01

Family

ID=45938999

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013534031A Active JP6071886B2 (ja) 2010-10-14 2011-10-14 脳損傷のバイオマーカー

Country Status (5)

Country Link
US (2) US9746481B2 (cg-RX-API-DMAC7.html)
EP (1) EP2628013B1 (cg-RX-API-DMAC7.html)
JP (1) JP6071886B2 (cg-RX-API-DMAC7.html)
IL (1) IL225731B (cg-RX-API-DMAC7.html)
WO (1) WO2012051519A2 (cg-RX-API-DMAC7.html)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2324360T3 (en) 2008-08-11 2018-05-14 Banyan Biomarkers Inc BIOMARKET DETECTION METHOD AND ASSAY OF NEUROLOGICAL CONDITION
HK1206425A1 (en) 2012-03-13 2016-01-08 The Johns Hopkins University Citrullinated brain and neurological proteins as biomarkers of brain injury or neurodegeneration
US9378551B2 (en) * 2013-01-03 2016-06-28 Siemens Aktiengesellschaft Method and system for lesion candidate detection
EP3757226A3 (en) 2013-07-17 2021-05-05 The Johns Hopkins University A multi-protein biomarker assay for brain injury detection and outcome
JP6312302B2 (ja) * 2014-01-06 2018-04-18 公益財団法人ヒューマンサイエンス振興財団 脳梗塞の診断マーカー
EP2896702A1 (en) * 2014-01-16 2015-07-22 University College Cork, National University Of Irland Cork A method of identifying a neonate at risk of having or developing hypoxic-ischaemic encephalopathy (HIE)
EP3166613A4 (en) 2014-07-09 2018-02-21 Duke University Compositions and methods for the repair of myelin
CN107003317B (zh) * 2014-10-06 2019-04-19 日内瓦大学 生物标记及其在脑损伤中的应用
US12422442B2 (en) 2014-10-06 2025-09-23 Universite De Geneve Markers and their use in brain injury
CN107533048A (zh) 2015-02-05 2018-01-02 美国免疫阵列公司 用于诊断脑损伤或神经退行性变的方法和组合物
US10557859B2 (en) 2015-05-05 2020-02-11 The Regents Of The University Of California Astrocyte traumatome and neurotrauma biomarkers
BR112019006710A2 (pt) * 2016-10-03 2019-06-25 Abbott Lab métodos aprimorados para avaliação do estado da uch-l1 em amostras de pacientes
EP3532496A1 (en) 2016-10-28 2019-09-04 Banyan Biomarkers, Inc. Antibodies to ubiquitin c-terminal hydrolase l1 (uch-l1) and glial fibrillary acidic protein (gfap) and related methods
CN110100182A (zh) * 2016-12-23 2019-08-06 苏珊娜·潘格拉茨-菲雷尔 α-B晶状体蛋白在诊断新生儿脑损伤中的作用
CN106645755B (zh) * 2016-12-30 2018-09-25 深圳大学 一种ad生物标记物及其检测方法
WO2018132676A1 (en) 2017-01-13 2018-07-19 Duke University Compositions and methods for the treatment of myelin related and inflammation related diseases or disorders
US11016092B2 (en) 2017-03-23 2021-05-25 Abbott Laboratories Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy-terminal hydrolase L1
US10877048B2 (en) 2017-04-15 2020-12-29 Abbott Laboratories Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury in a human subject using early biomarkers
CA3053410A1 (en) 2017-04-28 2018-11-01 Abbott Laboratories Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury using early biomarkers on at least two samples from the same human subject
US11709168B2 (en) 2017-05-23 2023-07-25 Brainbox Solutions, Inc. Biomarker levels and neuroimaging for detecting, monitoring and treating brain injury or trauma
CA3078725A1 (en) 2017-05-25 2018-11-29 Abbott Laboratories Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers
BR112019025387A2 (pt) 2017-05-30 2020-07-07 Abbott Laboratories métodos para auxiliar no diagnóstico e avaliação de uma lesão traumática cerebral branda em um indivíduo humano com o uso de troponina cardíaca i e biomarcadores precoces
CA3068041C (en) 2017-07-03 2024-06-25 Abbott Laboratories Improved methods for measuring ubiquitin carboxy-terminal hydrolase l1 levels in blood
EP3721228A4 (en) * 2017-12-06 2021-12-15 Flotbi Inc. ASSAY AND POINT OF CARE DEVICE USING SALIVA FOR DIAGNOSIS AND TREATMENT OF NEUROLOGICAL CONDITIONS AFFECTING BRAIN HEALTH
US11016105B2 (en) 2017-12-09 2021-05-25 Abbott Laboratories Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of GFAP and UCH-L1
WO2019113525A2 (en) 2017-12-09 2019-06-13 Abbott Laboratories Methods for aiding in the diagnosis and evaluation of a subject who has sustained an orthopedic injury and that has or may have sustained an injury to the head, such as mild traumatic brain injury (tbi), using glial fibrillary acidic protein (gfap) and/or ubiquitin carboxy-terminal hydrolase l1 (uch-l1)
EP3732489B1 (en) 2017-12-29 2025-10-22 Abbott Laboratories Novel biomarkers and methods for diagnosing and evaluating traumatic brain injury
CN108872589B (zh) * 2018-01-03 2021-09-03 深圳市人民医院 脑梗死外周血标志物及其应用
US20210041468A1 (en) * 2018-03-30 2021-02-11 National Center Of Neurology And Psychiatry Neonatal hypoxic-ischemic encephalopathy severity determining method and prognosis predicting method
WO2020102524A1 (en) * 2018-11-14 2020-05-22 Mark Evans Method and apparatus for reducing the risk of neonatal neurological injury
US20220016221A1 (en) * 2018-12-05 2022-01-20 Ipsen Biopharm Limited Treatment of symptoms of traumatic brain injury
CN110261617B (zh) * 2019-05-14 2022-07-01 深圳市人民医院 脑出血外周血标志物及其应用
CN110907422B (zh) * 2019-12-16 2021-07-06 吉林大学 基于Ti3C2的凝血酶适体传感器及其制备方法
WO2021234607A1 (en) * 2020-05-20 2021-11-25 St. Jude Children's Research Hospital Detection of alzheimer's disease using specific biomarkers
EP3982123A1 (en) * 2020-10-08 2022-04-13 Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca Markers and their use in brain injury
US20240108276A1 (en) * 2021-02-01 2024-04-04 The University Of Chicago Systems and Methods for Identifying Progression of Hypoxic-Ischemic Brain Injury

Family Cites Families (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3234412A (en) * 1961-07-21 1966-02-08 Babcock & Wilcox Co Thermionic conversion nuclear reactor
SE462454B (sv) 1988-11-10 1990-06-25 Pharmacia Ab Maetyta foer anvaendning i biosensorer
US5637459A (en) 1990-06-11 1997-06-10 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: chimeric selex
AU663053B2 (en) 1990-06-11 1995-09-28 Gilead Sciences, Inc. Nucleic acid ligands
US5660985A (en) 1990-06-11 1997-08-26 Nexstar Pharmaceuticals, Inc. High affinity nucleic acid ligands containing modified nucleotides
US5567588A (en) 1990-06-11 1996-10-22 University Research Corporation Systematic evolution of ligands by exponential enrichment: Solution SELEX
US6011020A (en) 1990-06-11 2000-01-04 Nexstar Pharmaceuticals, Inc. Nucleic acid ligand complexes
US5683867A (en) 1990-06-11 1997-11-04 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: blended SELEX
US5270163A (en) 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
US5707796A (en) 1990-06-11 1998-01-13 Nexstar Pharmaceuticals, Inc. Method for selecting nucleic acids on the basis of structure
US5496938A (en) 1990-06-11 1996-03-05 Nexstar Pharmaceuticals, Inc. Nucleic acid ligands to HIV-RT and HIV-1 rev
ATE242485T1 (de) 1993-05-28 2003-06-15 Baylor College Medicine Verfahren und massenspektrometer zur desorption und ionisierung von analyten
US5866434A (en) 1994-12-08 1999-02-02 Meso Scale Technology Graphitic nanotubes in luminescence assays
US6673533B1 (en) 1995-03-10 2004-01-06 Meso Scale Technologies, Llc. Multi-array multi-specific electrochemiluminescence testing
US6207369B1 (en) 1995-03-10 2001-03-27 Meso Scale Technologies, Llc Multi-array, multi-specific electrochemiluminescence testing
US6140045A (en) 1995-03-10 2000-10-31 Meso Scale Technologies Multi-array, multi-specific electrochemiluminescence testing
CN1661115A (zh) 1995-03-10 2005-08-31 梅索磅秤技术有限公司 多阵列、多特异性的电化学发光检验
US6319670B1 (en) 1995-05-09 2001-11-20 Meso Scale Technology Llp Methods and apparatus for improved luminescence assays using microparticles
NZ516848A (en) 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
US6413783B1 (en) 1997-09-18 2002-07-02 Meso Scale Technologies, Llc Assay sonication apparatus and methodology
CA2323638A1 (en) 1998-04-03 1999-10-14 Phylos, Inc. Addressable protein arrays
US6406921B1 (en) 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
US6780606B1 (en) 1999-02-26 2004-08-24 Synx Pharma, Inc. Method for diagnosing and distinguishing stroke and diagnostic devices for use therein
WO2000056934A1 (en) 1999-03-24 2000-09-28 Packard Bioscience Company Continuous porous matrix arrays
AU779635B2 (en) 1999-10-27 2005-02-03 Health Discovery Corporation Methods and devices for identifying patterns in biological systems and methods for uses thereof
SG144731A1 (en) 2000-07-18 2008-08-28 Correlogic Systems Inc A process for discriminating between biological states based on hidden patterns from biological data
AU2001291217A1 (en) 2000-09-22 2002-04-02 University Of Aarhus Novel compositions and methods for lymphoma and leukemia
US20030077590A1 (en) 2000-09-22 2003-04-24 Pedersen Finn Skou Methods for diagnosis and treatment of diseases associated with altered expression of neurogranin
EP1355727A4 (en) 2000-11-16 2007-04-11 Ciphergen Biosystems Inc METHOD OF ANALYSIS OF MASS SPECTRUM
US7113896B2 (en) 2001-05-11 2006-09-26 Zhen Zhang System and methods for processing biological expression data
US7144708B2 (en) 2001-06-25 2006-12-05 The Cleveland Clinic Foundation Markers of blood barrier disruption and methods of using same
US6884591B2 (en) 2001-06-25 2005-04-26 The Cleveland Clinic Foundation Peripheral marker of blood brain barrier permeability
WO2003001889A2 (en) 2001-06-29 2003-01-09 Meso Scale Technologies, Llc. Assay plates reader systems and methods for luminescence test measurements
JP4355214B2 (ja) 2001-07-30 2009-10-28 メソ スケイル テクノロジーズ，エルエルシー 発光試験測定用の固定化された脂質／タンパク質層を有するアッセイ用電極、その作製法、及びその使用法
ATE445160T1 (de) * 2001-08-20 2009-10-15 Biosite Inc Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon
EP2405019A1 (en) 2001-09-10 2012-01-11 Meso Scale Technologies LLC Methods, reagents, kits and apparatus for protein function analysis
US6919173B2 (en) 2001-09-10 2005-07-19 Meso Scale Technologies, Llc. Assay buffer, compositions containing the same, and methods of using the same
US20070098728A1 (en) 2001-09-24 2007-05-03 Pedersen Finn S Novel compositions and methods in cancer
JP4781628B2 (ja) 2001-12-05 2011-09-28 センス プロテオミック リミテッド 対立遺伝子改変体のためのタンパク質アレイおよびその使用
US20020193950A1 (en) 2002-02-25 2002-12-19 Gavin Edward J. Method for analyzing mass spectra
US7036946B1 (en) 2002-09-13 2006-05-02 Rockwell Collins, Inc. LCD backlight with UV light-emitting diodes and planar reactive element
CA2772050C (en) 2002-12-26 2016-09-06 Meso Scale Technologies, Llc. Assay cartridges and methods of using the same
EP1519194A1 (en) 2003-09-24 2005-03-30 Roche Diagnostics GmbH Use of gfap for identification of intracerebral hemorrhage
US7981362B2 (en) 2003-11-04 2011-07-19 Meso Scale Technologies, Llc Modular assay plates, reader systems and methods for test measurements
CA2578670C (en) 2004-04-15 2017-03-07 University Of Florida Research Foundation, Inc. Neural proteins as biomarkers for nervous system injury and other neural disorders
US8492107B2 (en) 2004-04-15 2013-07-23 University Of Florida Research Foundation, Inc. Neural proteins as biomarkers for nervous system injury and other neural disorders
US20140303041A1 (en) 2004-04-15 2014-10-09 University Of Florida Research Foundation Inc. In vitro diagnostic devices for nervous system injury and other neural disorders
US7456027B2 (en) 2004-04-15 2008-11-25 University Of Florida Research Foundation, Inc. Proteolytic biomarkers for traumatic injury to the nervous system
DK1766400T3 (da) 2004-06-03 2009-07-20 Meso Scale Technologies Llc Fremgangsmåde til at udföre fuldblodsanalyser
ES2428795T3 (es) 2004-06-25 2013-11-11 Washington University School Of Medicine Marcadores de daño cerebral
US20060257943A1 (en) 2005-01-25 2006-11-16 Cis Biotech, Inc. Ischemic biomarkers and their use to predict adverse neurological events from surgery
US7884260B2 (en) 2005-06-14 2011-02-08 University Of Chicago Cell-based screen for agents useful for reducing neuronal demyelination or promoting neuronal remyelination
GB2428240A (en) 2005-07-14 2007-01-24 Univ Gen Ve Diagnostic method for brain damage-related disorders
US20080026485A1 (en) 2006-04-18 2008-01-31 Wolfgang Hueber Antibody profiling for determination of patient responsiveness
WO2007136617A2 (en) 2006-05-18 2007-11-29 Walter Reed Army Institute Of Research (Wrair) Endothelial-monocyte activating polypeptide ii, a biomarker for use in diagnosis of brain injury
ES2443042T3 (es) 2006-10-16 2014-02-17 Bayer Intellectual Property Gmbh LTBP2 como biomarcador, diana terapéutica y diagnóstica
WO2008097618A1 (en) 2007-02-06 2008-08-14 University Of Florida Research Foundation, Inc. Synaptotagmin and collapsin response mediator protein as biomarkers for traumatic brain injury
EP2015196A1 (en) 2007-06-28 2009-01-14 Siemens Aktiengesellschaft Programmer interface for manufacturing execution system
WO2009143519A2 (en) 2008-05-23 2009-11-26 The Johns Hopkins University Biomarkers for myocardial ischemia
EP2143735A1 (en) 2008-07-10 2010-01-13 Institut Pasteur Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins
DK2324360T3 (en) 2008-08-11 2018-05-14 Banyan Biomarkers Inc BIOMARKET DETECTION METHOD AND ASSAY OF NEUROLOGICAL CONDITION
US20140342381A1 (en) 2008-08-11 2014-11-20 Banyan Biomarkers, Inc. Devices and methods for biomarker detection process and assay of neurological condition
US20170315136A9 (en) 2009-06-19 2017-11-02 Banyan Biomarkers, Inc. Biomarker assay of neurological condition
JP5909447B2 (ja) 2009-09-14 2016-04-26 バンヤン・バイオマーカーズ・インコーポレーテッド ニューロン損傷診断のためのマイクロｒｎａ、自己抗体およびタンパク質マーカー
GB201008541D0 (en) * 2010-05-21 2010-07-07 Univ Geneve Diagnostic methods
CN103460044B (zh) 2011-01-28 2016-04-20 西瑞斯实验室有限公司 用于检测肠和血脑屏障通透性的方法及其测试材料
US20140141458A1 (en) * 2011-05-12 2014-05-22 The Johns Hopkins University Assay reagents for a neurogranin diagnostic kit
WO2012170998A1 (en) 2011-06-10 2012-12-13 Cornell University Immobilized protein system for rapid and enhanced multiplexed diagnostics
WO2013173596A1 (en) 2012-05-16 2013-11-21 Trustees Of Boston University Chronic traumatic encephalopathy in blast-exposed individuals
US20150141528A1 (en) 2013-05-31 2015-05-21 Banyan Biomarkers, Inc. Neural specific s100b for biomarker assays and devices for detection of a neurological condition
WO2015066211A1 (en) 2013-10-29 2015-05-07 Banyan Biomarkers, Inc. Uch-l1 isoforms, assays and devices for detection of a neurological condition

Similar Documents

Publication Publication Date Title
JP2013545087A5 (cg-RX-API-DMAC7.html)
JP2015513370A5 (cg-RX-API-DMAC7.html)
Lee et al. CSF and brain indices of insulin resistance, oxidative stress and neuro-inflammation in early versus late Alzheimer’s disease
JP2016533499A5 (cg-RX-API-DMAC7.html)
Rota et al. Increased intrathecal TGF-β1, but not IL-12, IFN-γ and IL-10 levels in Alzheimer’s disease patients
Schwarz et al. Increased 3-hydroxykynurenine serum concentrations differentiate Alzheimer’s disease patients from controls
Lista et al. Tracking neuroinflammatory biomarkers in Alzheimer’s disease: a strategy for individualized therapeutic approaches?
BR112014006741A2 (pt) método para monitorização, diagnóstico e/ou prognóstico de lesão renal aguda no estágio inicial
JP6061935B2 (ja) 心的外傷後ストレス障害（ｐｔｓｄ）のための診断用バイオマーカーを検出及び監視するため、並びに同障害の自殺型と非自殺型とを識別するためのプロセス及びキット
WO2011094535A2 (en) Biomarkers of aging for detection and treatment of disorders
JP2014506244A5 (cg-RX-API-DMAC7.html)
WO2007136617A3 (en) Endothelial-monocyte activating polypeptide ii, a biomarker for use in diagnosis of brain injury
RU2014117671A (ru) Способ диагностики болезни альцгеймера (ad)
Yu et al. Diagnostic utility of VEGF and soluble CD40L levels in serum of Alzheimer's patients
RU2015116674A (ru) Способ диагностики или мониторинга почечной функции или диагностики почечной дисфункции
JP2024096748A (ja) アルファ－シヌクレイン病のアッセイ、方法、及び治療
NL2007112C2 (en) Novel diagnostic method for diagnosing depression and monitoring therapy effectiveness.
HRP20191862T1 (hr) Procjena rizika u liječenju antibioticima kod pacijenata koji boluju od primarne nezarazne bolesti određivanjem razine prokalcitonina
RU2009146803A (ru) Способ диагностики деструктивного панкреатита
BR112014007947A2 (pt) método para monitoramento, diagnóstico e/ou prognóstico de distúrbios relacionados à hipoxia usando nfat5
Ventura et al. Pancreatic Stone Protein Measurement to Screen and Diagnose Sepsis in the Context of the Surviving Sepsis Campaign Recommendations.
US20110129857A1 (en) Methods Of Detecting Or Monitoring Activity Of An Inflammatory Condition Or Neurodegenerative Condition
Kim et al. Association between common genetic variants of α2A-, α2B-and α2C-adrenoceptors and the risk of silent brain infarction
das Neves et al. Lipocalin-2 does not influence EAE clinical score but it increases inflammation in central nervous system
Varghese et al. Effect of anti-tuberculosis treatment on thyroid profile in newly detected smear positive pulmonary tuberculosis cases